End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0113 USD | -22.07% | +7.62% | -90.85% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Financials (USD)
Sales 2021 | 52.9M | Sales 2022 | 62.84M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2021 | -428M | Net income 2022 | -573M | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M | Net Debt 2022 | 84.53M | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | 949 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
1 day | -22.07% | ||
1 week | +7.62% | ||
1 month | -24.67% | ||
3 months | -43.50% | ||
6 months | -74.26% | ||
Current year | -90.85% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 88-12-31 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 14-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 12-03-31 |
David Lemus
BRD | Director/Board Member | 61 | 17-09-30 |
Jaisim Shah
BRD | Director/Board Member | 63 | 13-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.0113 | -22.07% | 49,497 |
24-05-30 | 0.0145 | +31.82% | 34,060 |
24-05-29 | 0.011 | +10.00% | 317,179 |
24-05-28 | 0.01 | -4.76% | 42,407 |
24-05-24 | 0.0105 | +16.67% | 23,572 |
End-of-day quote OTC Markets, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-90.85% | 6.14M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SRNE Stock